NCT04319978

Brief Summary

TThis is a comparative clinical study which will be conducted in OMFS department of DIKIOHS, DUHS Ojha Karachi. In this study the investigators will be comparing the effect of dexamethasone on pain and edema when administered pre-operatively vs post-operatively following surgery of impacted lower 3rd molars. Time duration of this study will be 2 months. A total of 100 patients will be considered in this study which will be equally divided into two groups; group A and group B (50 in each group).Group A will receive dexamethasone 1 hour pre-operatively while group B will receive the same post-operatively. All surgeries will be performed by the same maxillofacial surgeon and duration of surgery will be around 30-45 mins.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jul 2020

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

June 9, 2020

Status Verified

June 1, 2020

Enrollment Period

2 months

First QC Date

March 19, 2020

Last Update Submit

June 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Edema of face in the mandibular region

    edema will be assessed using a measuring tape in three facial planes (M1,M2,M3) M1: Tragus of Ear to Corner of Mouth M2: Tragus of Ear to Pogonion M3: Lateral Canthus of Eye to Angle of Mandible.

    Change in edema will be assessed from baseline at 1st, 3rd and 7th day post-operatively

Secondary Outcomes (1)

  • Change in Intensity of Pain in the extracted site: Visual Analog Scale (VAS)

    Change in the intensity of pain will be assessed from baseline to 1st, 3rd and 7th day post-operatively.

Study Arms (2)

Group A

ACTIVE COMPARATOR

Group A will receive single dose of dexamethasone IM 8mg 1 hour pre-operatively.

Drug: Dexamethasone injection

Group B

ACTIVE COMPARATOR

Group B will receive a single dose of dexamethasone IM 8mg immediately after surgery.

Drug: Dexamethasone injection

Interventions

Dexamethasone is a synthetic corticosteroid. Dexamethasone is an adequate measure for reducing pain and edema in the post-operative recuperation period following 3rd molar surgery. A single dose of IM 8mg dexamethasone will be used for each patient.

Also known as: Dexa
Group AGroup B

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients coming to dental OPD of DIKIOHS, DUHS, Ojha with Mesioangular impactions
  • Age of patients: 20-50 years

You may not qualify if:

  • Patients with known co-morbidities
  • Patients allergic to dexamethasone
  • Patients with history of recent anti-inflammatory drug intake(NSAIDs, steroids, or antihistamines)
  • Pregnant/lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Ishrat ul Ebad Khan Institute Of Health Sciences, DUHS, Ojha

Karachi, Sindh, 75330, Pakistan

Location

MeSH Terms

Interventions

Calcium DobesilateAbsorptiometry, Photon

Intervention Hierarchy (Ancestors)

BenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur CompoundsRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Arfa Baig, FCPS

    DIKIOHS, DUHS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arfa Baig, FCPS

CONTACT

Khadija Sultana, BDS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A total of 100 patients will be considered in this study which will be equally divided into two groups; group A and group B (50 in each group).Group A will receive dexamethasone 1 hour pre-operatively while group B will receive the same post-operatively.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Registrar

Study Record Dates

First Submitted

March 19, 2020

First Posted

March 24, 2020

Study Start

July 1, 2020

Primary Completion

September 1, 2020

Study Completion

November 1, 2020

Last Updated

June 9, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations